Revolutionizing Cancer Diagnostics
Blood tests for early cancer detection and disease monitoring
ABOUT US
Introducing ExoCellular Diagnostics ('EDx')
We are a pioneering biotechnology company specializing in liquid biopsy-based cancer diagnostic tests.
With headquarters in Cambridge, Massachusetts, USA and facilities in Munich, Germany, we are committed to developing and commercializing innovative liquid biopsy-based tests for cancer detection/diagnosis and disease monitoring.
Advanced Diagnostic Innovation